MedTrace Logo

Using Electrical Nerve Stimulation to Control Atrial Fibrillation

NCT04529941 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 46

Last updated 2025-10-02

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to examine if sending mild electrical signals just under your skin will improve atrial fibrillation symptoms by controlling your heart rate.

Conditions

Interventions

DEVICE

Device Implant with Active Treatment

ScNS at 3.5mA output for 2 weeks

DEVICE

Device Implant without Active Treatment

No device output for 2 weeks

Sponsors & Collaborators

  • Indiana University

    collaborator OTHER

  • National Institutes of Health (NIH)

    collaborator NIH

  • Cedars-Sinai Medical Center

    lead OTHER

Principal Investigators

  • Peng-Sheng Chen, MD · Cedars-Sinai Medical Center

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-11-24
Primary Completion
2024-09-04
Completion
2024-09-25
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04529941 on ClinicalTrials.gov